Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05297734 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

A NA study of Cancer and End of Life, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
2,996
Enrollment target
17
Study locations

NCT05297734 is a NA study of Cancer and End of Life that is actively recruiting participants, run by Stanford University. The registered enrollment target is 2,996 participants, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The trial reports 17 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05297734, a NA study of Cancer and End of Life, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
2,996 participants
Enrollment target
17
Study locations

Study Summary

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Conditions Studied

Cancer End of Life

Interventions

  • OTHER Receive technology-based supportive cancer care
  • BEHAVIORAL Receive redesigned team-based supportive cancer care

Study Locations (17)

California

  • Beckman Research Institute of City of Hope - Duarte
  • VA Medical Center, Fresno - Fresno
  • Santa Clara Valley Medical Center - Fruitdale
  • St Jude Heritage Medical Group - Fullerton
  • Oncology Institute for Hope and Innovation - Los Angeles
  • Sacramento VA Medical Center - VA Northern California Health Care System - Mather
  • Pacific Cancer Care - Monterey
  • VA Palo Alto - Palo Alto
  • Zuckerberg San Francisco General - San Francisco
  • Kaiser Foundation Research Institute - San Francisco
  • University of San Francisco - San Francisco
  • San Francisco VA Medical Center - San Francisco

Alabama

  • University of Alabama at Birmingham - Birmingham
  • University of South Alabama - Mobile

Hawaii

  • Spark M. Matsunaga VA Medical Center - Honolulu

Nevada

  • North Las Vegas VA Medical Center - Las Vegas

Utah

  • George E. Wahlen Department of Veterans Affairs Medical Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 2,996 participants
Start Date 2022-06-24
Est. Completion 2028-02-28
Phase NA

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05297734

The ClinicalTrials.gov registry entry for NCT05297734 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,996 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Receive technology-based supportive cancer care is the first listed.

NCT05297734 reports 17 study locations spanning 5 distinct geographic areas - top geographies include California, Alabama, Hawaii.

Frequently Asked Questions

What is clinical trial NCT05297734 about?

NCT05297734 is a clinical study titled "Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer". This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

What is the current status of trial NCT05297734?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,996 participants. The study started on 2022-06-24. Estimated completion is 2028-02-28.

What conditions does trial NCT05297734 study?

This clinical trial studies the following conditions: Cancer, End of Life.

What interventions are being tested in trial NCT05297734?

The interventions under investigation include: Receive technology-based supportive cancer care (OTHER), Receive redesigned team-based supportive cancer care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05297734?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05297734 being conducted?

This trial has 17 study locations across Alabama, California, Hawaii, Nevada, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

End of Life

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.